These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4992995)

  • 1. Syntheses and biological activity of 5-aminoimidazoles and 5-triazenoimidazoles.
    Shealy YF
    J Pharm Sci; 1970 Nov; 59(11):1533-58. PubMed ID: 4992995
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzene analogs of triazenoimidazoles.
    Shealy YF; O'Dell CA; Clayton JD; Krauth CA
    J Pharm Sci; 1971 Sep; 60(9):1426-8. PubMed ID: 5105894
    [No Abstract]   [Full Text] [Related]  

  • 3. Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1.
    Cheung M; Kuntz KW; Pobanz M; Salovich JM; Wilson BJ; Andrews CW; Shewchuk LM; Epperly AH; Hassler DF; Leesnitzer MA; Smith JL; Smith GK; Lansing TJ; Mook RA
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6214-7. PubMed ID: 18929484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacological properties of preparations from the aziridinyl triazine group].
    Stukov AN; Filov VA; Kon'kov SA; Ivin BA
    Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and chemistry of fluorine containing bioactive 1,2,4-triazines--an overview. Chemistry of uncondensed 1,2,4-triazines, Part III.
    Abdel-Rahman RM
    Pharmazie; 1999 Nov; 54(11):791-803. PubMed ID: 10603605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some substituted imidazo[1,2-b] [1,2,4]triazines and 8H-pyrimido[1,2-b] [1,2,4]triazin-8-ones as potential antineoplastic agents.
    Labouta IM; Soliman FS; Kassem MG
    Pharmazie; 1986 Nov; 41(11):812-3. PubMed ID: 3562515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors].
    Schmähl D
    Planta Med; 1968; ():3-12. PubMed ID: 4976078
    [No Abstract]   [Full Text] [Related]  

  • 8. [On some biological effects of the cytostatic agent verrucarin A].
    Rüsch ME; Stähelin H
    Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15,774.
    Evans JS; Gerritsen GC; Mann KM; Owen SP
    Cancer Chemother Rep; 1965 Oct; 48():1-6. PubMed ID: 4953644
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential antineoplastics I: substituted 3,5-dioxo-and 3-thioxo-5-oxo-2,3,4,5-tetrahydro-1,2,4-triazines.
    Ibrahim el-SA ; Shams el-Dine SA; Soliman FS; Labouta IM
    J Pharm Sci; 1979 Feb; 68(2):243-5. PubMed ID: 423100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial activities of some 3,5-diamino-as-triazine derivatives.
    Rees RW; Russell PB; Foell TJ; Bright RE
    J Med Chem; 1972 Aug; 15(8):859-61. PubMed ID: 5044307
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic chemotherapy of mammary carcinoma.
    Shingleton WW; Sedransk N; Johnson RO
    Ann Surg; 1971 Jun; 173(6):913-9. PubMed ID: 4102924
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitroheterocyclic antimicrobial agents. 1-Methyl-2-nitro-5-imidazolyl derivatives.
    Asato G; Berkelhammer G
    J Med Chem; 1972 Oct; 15(10):1086-8. PubMed ID: 4560746
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs on the horizon in bronchogenic carcinoma.
    Carter SK
    Cancer; 1972 Nov; 30(5):1402-9. PubMed ID: 4117256
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor.
    Yu T; Zhang Y; Kerekes AD; Tagat JR; Doll RJ; Xiao Y; Esposite S; Hruza A; Belanger DB; Voss M; Rainka MP; Basso A; Liu M; Liang L; Sui N; Prelusky D; Rindgen D; Zhang L
    Bioorg Med Chem Lett; 2018 May; 28(8):1397-1403. PubMed ID: 29545102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

  • 17. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and antibacterial and antitumoral activity of some methylhydrazonium salts of pyrimidine bases and their analogues (author's transl)].
    Golovinsky E; Karamanov G; Spassovska N; Maneva L; Spassov A
    Pharmazie; 1982 May; 37(5):355-6. PubMed ID: 7111362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of polyriboinosinic: polyribocytidylic acid, a new antiviral and antitumor agent.
    Adamson RH; Fabro S; Homan ER; O'Gara RW; Zendzian RP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():148-52. PubMed ID: 4990370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.